Japan, the second largest pharmaceutical market in the world, presents a number of opportunities.
Easing of regulatory guidelines, an ageing population and a strong product pipeline provide a strong impetus for growth in the pharmaceutical industry. Although the increasing market share of generics may dampen market value, this represents a great deal of opportunity for generic manufacturers.
Given the massive development costs that it faces, the pharmaceutical industry in Japan is undergoing changes, such as restructuring through mergers and acquisitions, and as a result the business environment in which pharmaceutical companies find themselves is transforming rapidly. Much is expected of Japanese pharmaceutical industry as a strategic industry in the 21st century.
In this context, the 28th INTERPHEX JAPAN and 9th in-PHARMA JAPAN taking place at Tokyo Big Sight from July 1 to 3, 2015 hold special significance as it reflects the dynamic changes taking place in the Japanese pharmaceutical industry.
With more than1,000 exhibitors and 35,000 visitors expected from around the world,the 28th INTERPHEX JAPAN ( Int'l Pharmaceutical R&D and Manufacturing Expo/Conference )and 9th in-PHARMA JAPAN ( Int'l Pharmaceutical Ingredients Expo & Conference) serve as the best business platform to see, touch and make practical comparison of the latest, innovative products/technologies from Japan, Asia and the rest of the world.
INTERPHEX JAPAN is one of the world's leading pharmaceutical exhibitions, covering the whole process of pharmaceutical R&D and manufacturing, from all kinds of equipment to lab devices, contract services, packaging, and total solutions. in-PHARMA JAPAN is a concurrent show which is considered the best business platform for pharmaceutical ingredients suppliers to expand sales and network in the Japanese pharmaceutical industry.
Firmly established as Japan's significant pharmaceutical expo for industry professionals, the event has been expanding its scale every year.
Interphex Japan will be the best event for the people who are seeking for latest information pertaining to pharmaceutical industry. The professionals of pharmaceutical industry linked to manufacturing technology, R&D, product quality control, factory control, purchasing / facilities, information technology and lots more will come to this event as visitor. Interphex Japan will be beneficial for all the participants as they will be able to see actual products and technologies, meet face-to-face with potential partners, find solutions to the needs and requirements and many more. The manufacturers of this industry will demonstrate their latest products and services before the target audiences.
INTERPHEX JAPAN and in-PHARMA JAPAN have become a bridge between overseas companies and Japanese companies. The event has been contributing to the growth and innovation of the Japanese pharmaceutical industry for many years, generating new business opportunities for exhibitors and visitors. With Japan being the world’s second largest market, the exhibition is now firmly established as one of the world’s leading pharmaceutical shows to get the latest trends and learn the new technologies.
This mega pharmaceutical event is organised by Reed Exhibitions Japan Ltd,which has a worldwide reputation for high-quality and large-scale exhibitions. Japan’s largest trade show organizer has been contributing to the growth and innovation of the Japanese pharmaceutical industry for many years, generating new business opportunities for exhibitors and visitors.
Equipment Maintenance Zone
One of the highlights of this year’s event is the new zone called “Equipment Maintenance Zone” which is specialised in surface finishing, machining techniques, machine components/materials, and maintenance services. Other popular zones are the Korea Pavilion and the India Pavilion. These two large international pavilions will surely be more attractive with support from their national organizations.
According to the organizers, many brand-new products will be unveiled at the show this year as well. Just to name a few, a scaled up version of M Technique Co.'s forced thin-film microreactor, Ulrea SS-300, will be exhibited on-site. Nippon Becton Dickinson Company Ltd. will perform demonstrations of the new MicroBio µ3D colony rapid fully automated detection system.
Kyoto Electronics Manufacturing Co. Ltd. will also introduce their Electro Magnetically Spinning Viscometer publicly for the first time.
The conference program is also one of the main attractions of the event. The program offers a total of 140 sessions throughout the show period, covering the entire range of current issues and topics in the pharmaceutical field: pharmaceuticals, life science, drug discovery, cosmetic R&D, product planning and more.
The last year event
From July 2 to 4, 2014, the 27th INTERPHEX JAPAN and 8th in-PHARMA JAPAN were held at Tokyo Big Sight with 942 exhibitors and 32,974 visitors. As Japan’s largest pharmaceutical event, the total number of visitors expanded notably compared to that of the previous year.
In particular, the highlights of the last year event were the Indian Pavilion and the Korean Pavilion which led to an increase in the number of overseas exhibitors.
The first ever “Partner Country” of INTERPHEX JAPAN and in-PHARMA JAPAN was India, which is increasing its presence in the world’s pharmaceutical industry. India is among the top six producers of pharmaceuticals in the world and ranks fourth in terms of total pharma market share in the Asia Pacific.
Senior officials from the Department of Commerce, along with representatives from the Federation of Indian Commerce and Industry (Ficci) and a large contingent of Indian business leaders, represented the Brand India Pharma at the Indian Pavilion during the show. Rajeev Kher, Commerce Secretary of Ministry of Commerce and Industry, also gave a talk in the Keynote Session on “The India Pharmaceutical Industry - Hidden Potential Power “. Mainly organized by Ficci, the India Pavilion served as the meeting ground for many Japanese leaders and companies in the pharmaceutical industry. “Both Japan and India are progressing well in various areas of today’s pharmaceutical business. We should extend further cooperation and partnership between the two countries,” said Rajeev Kher.
Actual equipment and products were displayed at each booth and detailed technical consultations were conducted as well. The year 2014s number of overseas exhibitors has almost doubled since the previous show. The majority of them were from major pharmaceutical producing countries such as USA, Germany, Italy, Switzerland, the Netherland, Republic of Korea, China, Taiwan, and Indonesia. In addition to many overseas suppliers attending the show at their distributors’ booths, more and more companies tend to have their own booth to focus on the Japanese market.